参·考·文·献

更新于 2026年11月16日 版权声明
参·考·文·献

[1] 冯友贤. 血管外科学[M]. 2版. 上海:上海科学技术出版社, 1985.

[2] 张荣林, 施广飞, 周素真, 等. 支架内再狭窄的介入治疗[J]. 中华医学杂志(英文版) , 2001, 114:67.

[3] 姜卫剑, 李选, 任安, 等. 脉冲-喷射溶栓治疗腘动脉栓塞[J]. 中华放射性杂志, 1996, 30:301-305.

[4] 包俊敏. 下肢动脉闭塞性疾病腔内治疗进展[J].中国普外基础与临床杂志, 2010, 17:645-648.

[5] 李选, 姜卫剑, 朱建刚, 等. Strecker支架在治疗外周动脉狭窄或闭塞性疾患中的应用[J]. 中华放射学杂志, 1996, 30:296-300.

[6] 姜卫剑, 吴朝阳, 刘伟, 等. 经皮经腔介入治疗技术在动脉狭窄性疾病中的应用[J]. 中华放射性杂志, 2000, 34:528-530.

[7] 包俊敏, 梅志军.如何规范应用导管溶栓术治疗动脉闭塞性疾病[J].临床误诊误治, 2014,27:42-45.

[8] Allaire E, Melliere D, Poussier B, et al. Iliac artery rupture during balloon dilatation: what treatment?[J]. AnnVasc Surg, 2003, 17:306-314.

[9] Dauerman H L, Applegate R J, Cohen D J. Vascular closure devices: the second decade[J]. J Am Coll Cardiol, 2007, 50:1617-1626.

[10] Kelm M, Perings S M, Jax T, et al. Incidence and clinical outcome of iatrogenic femoral arteriovenous fistulas: implications for risk stratifiation and treatment[J]. J Am Coll Cardiol, 2002, 40:291-297.

[11] Koreny M, Riedmüller E, Nikfardjam M, et al. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis[J]. JAMA, 2004, 291:350-357.(https://www.daowen.com)

[12] Piper W D, Malenka D J, Ryan T J Jr, et al. Predicting vascular complications in percutaneous coronary interventions[J]. Am Heart J, 2003, 145:1022-1029.

[13] Streiff M B. Vena caval fiters: a review for intensive care specialists[J]. J Intensive Care Med, 2003, 18:59-79.

[14] Tavris D R, Gallauresi B A, Lin B, et al. Risk of local adverse events following cardiaccatheterization by hemostasis device use and gender[J]. J Invasive Cardiol, 2004, 16:459-464.

[15] Webber G W, Jang J, Gustavson S, et al. Contemporary management of postcatheterization pseudoaneurysms[J]. Circulation, 2007, 115:2666-2674.

[16] Tunesen K H, Sager P, Karle A, et al. Percutaneous transluminal angioplasty of the superficial artery by retrograde catheteration via the poplitealartery[J]. Cardiovasc Interv Radiol, 1988, 1:127.

[17] Yuan L, Bao J, Zhao Z, et al. Endovascular therapy for long-segment atherosclerotic aortoiliac occlusion[J]. J Vasc Surg, 2014, 59:663-668.

[18] Yuan L, Bao J, Zhao Z, et al. Transbrachial and femoral artery approach endovascular therapy for flush infrarenal aortic occlusion[J]. Eur J Vasc Endovasc Surg, 2014, 48:46-52.

[19] Bonelli F C, McKusick M A, Textor S C, et al. Renal artery angioplasty: Technical results and clinical outcome in 320 patients[J]. Mayo Clin Proc, 1995, 70(11):1041-1047.

[20] Plouin P F, Dame B, Chatellier G, et al. Restenosis after a first percutaneous transluminal renal angioplasty[J]. Hypertension, 1993, 21(1):89-93.

[21] Dotter C T, Judkins M P. Transluminal treatment of arteriosclerotic obstructions: Description of a new technique and a preliminary report of it’s applications[J]. Circulation, 1964, 30:654.

[22] Katzen B T, Chang J, Knox W G. Percutaneous transluminal angioplasty with the Grüntzig balloon catheter: a review of 70 cases[J]. Arch Surg, 1979, 114:1389.

✍AI写作